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•

To assess the number of patients prescribed diabetic regimens consistent with
American Diabetes Association (ADA) Standards of Care recommendations upon
hospital discharge.1

BACKGROUND
• Patients with diabetes are commonly prescribed complex medication regimens
requiring frequent adjustments to ensure safety and efficacy.
• The American Diabetes Association (ADA) recommends that patients with type 2
diabetes admitted to the hospital have oral diabetes medications held and insulin
therapy initiated.2
• Though insulin is preferred while inpatient, it is not a common first line agent in
outpatient therapy.
• It has been reported that patients’ diabetes discharge regimens may be
inconsistent with either ADA Standards of Care recommendations or patients’ own
previous diabetes regimen.
• A recent study employed pharmacists to conduct medication reviews at hospital
admission and discharge for diabetic patients and 29.4% of patients had at least
one medication error.3
• Focusing on diabetic transitions of care from inpatient to outpatient has been
associated with reduced hospital readmission rates.4

Table 1.

Figure 3. Percentage of Patients
Discharged with New Insulin

Table 2.

Baseline Characteristics
Age (median age in years, IQR)
Male (n, %)
BMI (median BMI, IQR)
Past Medical History (n, %)
ACS/MI, angina, and/or PAD
Stroke/TIA
Renal dysfunction
Smoking
A1c (median %, IQR)
CrCl (median mL/min, IQR)
Steroid use inpatient (n, %)

n=5495
67 (58-76)
2809 (51%)
33 (28-39)
995 (18%)
621 (11%)
1852 (34%)
965 (18%)
7.8 (7.0-9.1)
55 (36-81)
990 (18%)

Characterization of Discharge Regimens
n=5495
Inconsistent with Standards of Care
n=478
Bolus started prior to starting basal
241 (50.4%)
Basal and/or bolus inappropriately started
177 (37.0%)
Started multiple agents concomitantly
36 (7.5%)
Unclear reason for not initiating metformin
20 (4.1%)
DPP-4 + GLP-1
4 (0.84%)
Consistent with Standards of Care
n=5016
No changes at discharge
3966 (79.1%)
No new meds at discharge
575 (11.4%)
Standards of Care consistent changes
475 (9.5%)

Figure 1. Discharge Regimen Consistent with Standards of Care or Own
Previous Home Regimen

n=478 (8.7%)
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Figure 2. Discharge Regimen Consistent with Standards of Care or Own Previous Home
Regimen: A1c Subgroup Analysis
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• Although over 91% of patients were discharged on ADA Standards of Care consistent
regimens, there remain opportunities for improvement.
• Nearly 90% of inconsistent discharge regimens related to inappropriate initiation of
insulin at discharge, which may indicate over-use of insulin after hospitalization.
• Over 50% of patients with inconsistent regimens had bolus insulin initiated without
prior basal insulin which may be indicative of patients getting discharged on sliding
scale insulin—these patients may be good candidates for oral or non-insulin agents.
• Almost 20% of patients received corticosteroids while inpatient, which may have
played a part in these decisions at discharge.
• A numerically larger portion of patients in the A1c ≤10% group had discharge
regimens inconsistent with Standards of Care.
• This specific group would likely have more appropriate opportunity to start noninsulin agents upon discharge, such as metformin, GLP-1 agonists and SGLT-2
inhibitors that have significant evidence to support use as first line agents.
• Over 300 patients, or 6.4% of patients included in this study had insulin discontinued
after hospital discharge.
• There are risks associated with unnecessary initiation of insulin, including safety in
patients newly introduced to these agents as well as additional financial burden.
• Unnecessary initiation of insulin also provides burden to outpatient providers,
including pharmacists, as discontinuation of new prescriptions may contribute to
further patient confusion and distrust of healthcare providers.
• This study was limited by retrospective design and lack of sufficient documentation for
therapeutic decisions regarding discharge regimens, potentially skewing data.
• The findings of this study suggest opportunity for provider education, creation of
discharge tools, and potential pharmacist intervention to ensure discharge regimens
are consistent with ADA Standards of Care and to prevent unnecessary changes and
confusion for patients.
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Figure 4. Percentage of Patients with Any Insulin
Discontinued at First Office Visit Post-Hospitalization

DISCUSSION & CONCLUSIONS

n=5016 (91.3%)

METHODS
• Study Design: Institutional Review Board (IRB) approved retrospective chart
analysis of patients with type 2 diabetes admitted to a Parkview hospital between
July 1, 2019 and July 1, 2021.
• Inclusion Criteria (must meet all):
• HbA1c ≥6.5% in 90 days before or after hospitalization
• Type 2 diabetes diagnosis
• At least two blood glucose readings >180 mg/dL during hospitalization
• Exclusion Criteria (must not meet any):
• Diagnosis of type 1 diabetes
• Received parenteral nutrition or tube feeds during hospitalization
• Discharged to hospice
• Primary Outcome: Number of patients prescribed diabetic regimens consistent
with Standards of Care recommendations or their own previous diabetes regimen
upon hospital discharge
• Secondary Outcomes:
• Patients with HbA1c >10% discharge regimen consistent with Standards of Care
or own previous home regimen
• Patients with HbA1c ≤10% discharge regimen consistent with Standards of Care
or own previous home regimen
• Percentage of patients discharged with new basal, bolus, or basal and bolus
insulin
• Percentage of patients discharged with any insulin that was discontinued at
patient’s first primary care visit post-hospitalization
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